Most Recent

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

image: Opinion: #IceBucketChallenge, Investing Well

Opinion: #IceBucketChallenge, Investing Well

By | September 10, 2014

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

3 Comments

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

1 Comment

image: Opinion: Research, Restricted

Opinion: Research, Restricted

By | July 8, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

4 Comments

image: Opinion: Does Social Media “Like” Conservation?

Opinion: Does Social Media “Like” Conservation?

By , , and | April 8, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

3 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

image: Opinion: Biodiversity Impacts Humanity

Opinion: Biodiversity Impacts Humanity

By | February 20, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

2 Comments

image: Opinion: Paradoxical Amphibians

Opinion: Paradoxical Amphibians

By | February 7, 2013

A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech